Long-term colorectal-cancer incidence and mortality after lower endoscopy
- PMID: 24047059
- PMCID: PMC3840160
- DOI: 10.1056/NEJMoa1301969
Long-term colorectal-cancer incidence and mortality after lower endoscopy
Abstract
Background: Colonoscopy and sigmoidoscopy provide protection against colorectal cancer, but the magnitude and duration of protection, particularly against cancer of the proximal colon, remain uncertain.
Methods: We examined the association of the use of lower endoscopy (updated biennially from 1988 through 2008) with colorectal-cancer incidence (through June 2010) and colorectal-cancer mortality (through June 2012) among participants in the Nurses' Health Study and the Health Professionals Follow-up Study.
Results: Among 88,902 participants followed over a period of 22 years, we documented 1815 incident colorectal cancers and 474 deaths from colorectal cancer. With endoscopy as compared with no endoscopy, multivariate hazard ratios for colorectal cancer were 0.57 (95% confidence interval [CI], 0.45 to 0.72) after polypectomy, 0.60 (95% CI, 0.53 to 0.68) after negative sigmoidoscopy, and 0.44 (95% CI, 0.38 to 0.52) after negative colonoscopy. Negative colonoscopy was associated with a reduced incidence of proximal colon cancer (multivariate hazard ratio, 0.73; 95% CI, 0.57 to 0.92). Multivariate hazard ratios for death from colorectal cancer were 0.59 (95% CI, 0.45 to 0.76) after screening sigmoidoscopy and 0.32 (95% CI, 0.24 to 0.45) after screening colonoscopy. Reduced mortality from proximal colon cancer was observed after screening colonoscopy (multivariate hazard ratio, 0.47; 95% CI, 0.29 to 0.76) but not after sigmoidoscopy. As compared with colorectal cancers diagnosed in patients more than 5 years after colonoscopy or without any prior endoscopy, those diagnosed in patients within 5 years after colonoscopy were more likely to be characterized by the CpG island methylator phenotype (CIMP) (multivariate odds ratio, 2.19; 95% CI, 1.14 to 4.21) and microsatellite instability (multivariate odds ratio, 2.10; 95% CI, 1.10 to 4.02).
Conclusions: Colonoscopy and sigmoidoscopy were associated with a reduced incidence of cancer of the distal colorectum; colonoscopy was also associated with a modest reduction in the incidence of proximal colon cancer. Screening colonoscopy and sigmoidoscopy were associated with reduced colorectal-cancer mortality; only colonoscopy was associated with reduced mortality from proximal colon cancer. Colorectal cancer diagnosed within 5 years after colonoscopy was more likely than cancer diagnosed after that period or without prior endoscopy to have CIMP and microsatellite instability. (Funded by the National Institutes of Health and others.).
Comment in
-
Colorectal-cancer screening--coming of age.N Engl J Med. 2013 Sep 19;369(12):1164-6. doi: 10.1056/NEJMe1308253. N Engl J Med. 2013. PMID: 24047066 No abstract available.
-
Colorectal-cancer incidence and mortality after screening.N Engl J Med. 2013 Dec 12;369(24):2354-5. doi: 10.1056/NEJMc1313116. N Engl J Med. 2013. PMID: 24328473 No abstract available.
-
Colorectal-cancer incidence and mortality after screening.N Engl J Med. 2013 Dec 12;369(24):2355. doi: 10.1056/NEJMc1313116. N Engl J Med. 2013. PMID: 24350357 No abstract available.
-
Lower endoscopy and prevention of colon cancer.Gastroenterology. 2014 Jul;147(1):245-6. doi: 10.1053/j.gastro.2014.05.019. Epub 2014 May 24. Gastroenterology. 2014. PMID: 24866428 Free PMC article. No abstract available.
-
Reply: To PMID 24047059.Gastroenterology. 2014 Jul;147(1):246-7. doi: 10.1053/j.gastro.2014.05.018. Epub 2014 May 24. Gastroenterology. 2014. PMID: 24866432 No abstract available.
References
-
- Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010;375:1624–33. - PubMed
-
- Segnan N, Armaroli P, Bonelli L, et al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial — SCORE. J Natl Cancer Inst. 2011;103:1310–22. - PubMed
-
- Bretthauer M. The capsule and colorectal-cancer screening — the crux of the matter. N Engl J Med. 2009;361:300–1. - PubMed
-
- Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastro-enterology. 2012;143:844–57. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P01 CA087969/CA/NCI NIH HHS/United States
- P30 DK043351/DK/NIDDK NIH HHS/United States
- R01 CA137178/CA/NCI NIH HHS/United States
- P01 CA87969/CA/NCI NIH HHS/United States
- P01 CA55075/CA/NCI NIH HHS/United States
- UM1 CA167552/CA/NCI NIH HHS/United States
- P50 CA127003/CA/NCI NIH HHS/United States
- CAF/10/15/CSO_/Chief Scientist Office/United Kingdom
- P01 CA055075/CA/NCI NIH HHS/United States
- R01 CA151993/CA/NCI NIH HHS/United States
- 1UM1 CA167552/CA/NCI NIH HHS/United States
- K24 DK098311/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials